Why the study?
Does combined treatment with celiprolol and candesartan improve cardiac function and remodeling in a rat model of isoproterenol-induced heart failure?
Population
Rats with heart failure induced by isoproterenol (ISO) 300 mg/kg injection (n=32)
Comparison
Celiprolol 10 mg/kg per day, candesartan 0.2… vs Vehicle
Design
Preclinical, divided into 4 groups
Follow-up
4 weeks
Authors
Loading...
Supports testing celiprolol-candesartan synergy in HF; hypothesis-generating from rat model and leaves clinical translation open.
Does combined treatment with celiprolol and candesartan improve cardiac function and remodeling in a rat model of isoproterenol-induced heart failure?
Combination therapy with celiprolol and candesartan provides synergistic cardioprotective effects in experimental heart failure through distinct mechanisms.
Mori et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: